| |
|
|
|
|
|
|
|||
|
Blood, 15 May 2008, Vol. 111, No. 10, pp. 5008-5016. Prepublished online as a Blood First Edition Paper on March 4, 2008; DOI 10.1182/blood-2007-11-122259.
IMMUNOBIOLOGY A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo1 Centre d'Immunologie de Marseille-Luminy, Université de la Méditerranée, Marseille, France; 2 Inserm U631, Marseille, France; 3 Centre National de la Recherche Scientifique (CNRS), UMR6102, Marseille, France; 4 Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France; 5 Laboratoire de Génétique Humaine des Maladies Infectieuses, Inserm U550, Paris, France; 6 Université Paris René Descartes, Faculté de Médecine Necker, Paris, France; 7 Department of Molecular Microbiology and Immunology, Brown University, Providence, RI; 8 Service de Pédiatrie, Centre Hospitalier Universitaire (CHU), St Etienne, France; 9 Department of Pediatrics, Infectious Diseases, Clinical Immunology and Allergy Division, Cerrahpaçsa Medical School, Istanbul University, Istanbul, Turkey; 10 Pediatric Department, Soroka Medical Center, Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel; 11 Department of Pediatrics, King Faysal Hospital and Research Center, Riyadh, Saudi Arabia; 12 Service d'Immunopathologie, Hôpital Saint-Louis, Paris, France; and 13 Unité d'Immuno-Hématologie, Hôpital Necker, Paris, France
Natural killer (NK) cells have been originally defined by their "naturally occurring" effector function. However, only a fraction of human NK cells is reactive toward a panel of prototypical tumor cell targets in vitro, both for the production of interferon-
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||